Susquehanna International Group, LLP Rani Therapeutics Holdings, Inc. Call Options Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
Call Options
1 transactions
Others Institutions Holding RANI
# of Institutions
47Shares Held
3.68MCall Options Held
44KPut Options Held
193K-
Vanguard Group Inc Valley Forge, PA710KShares$1.18 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$819,3490.67% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$744,4960.04% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$502,5530.01% of portfolio
-
Two Sigma Investments, LP New York, NY291KShares$483,6920.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $40.7M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...